Trusted by Sponsors
Since 1974

Here at Abond CRO (formerly known as QST Consultations), our belief in partnering to improve healthcare has led to decades of success. Talk to our long-standing clients and they’ll tell you that we’re not a vendor, we’re a part of their team. That our relationship is seamless and collaborative, and our contributions authoritative and trusted.

Today we serve universities, medical device manufacturers and pharmaceutical companies, delivering the expertise and personalized service needed to advance healthcare. Because we understand that each trial is unique, our staff leverages our years of technical expertise to tailor our solution to the specific needs of each client — from startups to multinational life sciences organizations.

About ABOND

Our Core Principles

HONESTY

We value the truth above all else and seek it continually.

FOCUS

We keep the big picture in mind while sweating every detail.

RESPONSIBILITY

We take pride in our work and own every decision.

ABOND History

Secure, Custom-built Facilities

In January of 2010 we moved into our central facility, specially designed for safety and data security after in-depth consultation with our sponsors, IT professionals, geothermal heating experts, and structural engineers. Our state-of-the-art computing system supports clients 24/7, protecting the confidentiality and integrity of client data.

Our Leadership Team

Phil Doren, PhD
Phil Doren, PhDChief Executive Officer
Dr. Phil Doren is responsible for expanding the company’s service offerings, corporate leadership, risk mitigation, cultivating strategic business opportunities, fostering our well-renowned industry reputation and developing leaders within the organization. Phil has over 25 years of experience in developing and managing partnerships in the CRO industry. He is a decisive leader who has been successful in improving product development programs through high quality data collections completed in reduced time frames.
John Quiring, PhD
John Quiring, PhDFounder & Chief Science Officer
John is principally a scientist and has applied his statistical education interactively with clients/sponsors, regulatory officials, and co-workers with the goal of advancing the availability of medical products for over 40 years. As founder of QST, the predecessor name of Abond CRO Inc., he spearheaded the approval of over 90 regulatory submissions participating in strategic FDA / sponsor meetings, performing statistical analyses as well as directing the company’s work efforts. He has served as CEO and is now the Chief Scientific Officer and a member of the Board of Directors.
Veronica Powell, MS, MAS
Veronica Powell, MS, MASChief Operating Officer
As Abond’s Chief Operating Officer, Veronica is passionate for delivering innovative and client-centric solutions to clinical trial operations. Veronica has an established track record as an effective leader in the industry and within her role at Abond where she ensures the delivery of solutions which are on-time, on-budget and with high quality.
Jason Proos, MS
Jason Proos, MSChief Technology Officer
Jason Proos joined QST (now Abond) in 1999. Jason is responsible for planning, designing, purchasing, installing, monitoring, operating, and maintaining Abond’s IT infrastructure. Jason earned his Masters of Science in Statistics from Western Michigan University.
Charley Bratton
Charley BrattonSenior Vice President Corporate Marketing & Sales
Charley has 30 years’ experience selling to and for CROs, with emphasis on new/enhanced technologies/services built to improve clinical research. His approach is based on partnering with our clients, focusing on meeting their goals as well as ABOND’s. Charley has held senior sales/management positions at CISYS Lifesciences, Acorn Applications, Gobalto, Inclinix, PHT, Datalabs, and eResearch Technology.
Diane Blickley, MBA
Diane Blickley, MBADirector of Finance & Strategy
Diane Blickley has over 20 years of extensive experience in accounting and financial leadership. Diane is responsible for study proposals, contracts, a comprehensive set of controls, financial & project reports, financial strategy and budgets designed to mitigate risk, enhance the accuracy of the company’s reported financial results, and ensure that reported results comply with generally accepted accounting principles.
Jayne Stegman, BS
Jayne Stegman, BSManager of Human Resources & Administration
Jayne Stegman joined Abond CRO in February, 2017. She is responsible for Human Resources Management and Administration.
Jayne earned her Bachelor of Science in Business Administration from Aquinas College in Grand Rapids, MI.
Brian Armstrong, MS
Brian Armstrong, MSDirector of Clinical Data Standards & Statistical Programming
Brian’s broad experience encompasses a multitude of successful drug and device submissions to regulatory authorities, providing the essential skills for keeping Abond in compliance with regulatory data collection and submission requirements. With Brian’s high attention to detail, he helps our clients navigate the complex clinical data environment.
Lori Davis, PhD
Lori Davis, PhDDirector of Biostatistical Consulting
Dr. Lori Davis leverages her extensive industry experience, statistical prowess and exceptional communication skills to oversee consulting services at Abond. She serves as a statistical advisor to our clients by providing guidance at various client, scientific advisory committee and regulatory agency meetings around the globe. Dr. Davis is committed to collaborating on projects serving Abond’s clients, providing unparalleled value in developing cooperative and constructive long term relationships bringing efficiency and rigor to her client’s development programs and products.
Carolyn Wright, MS
Carolyn Wright, MSDirector of Clinical Operations
Carolyn Wright has over 16 years of drug and medical device experience in areas of clinical efficacy and safety, quality assurance, regulatory affairs, trial stage and commercial product manufacturing. She has a Six Sigma Black Belt and has managed multiple ANDA transdermal product development programs as well as global regulatory and safety assessments for new topical, nutritional and medical device products. Carolyn Wright’s combined clinical, quality, operational and global regulatory experience has enabled her to lead teams to successful trial execution while ensuring exceptional quality.

Our Board of Directors

John Quiring, PhDChairman
John is principally a scientist and has applied his statistical education interactively with clients/sponsors, regulatory officials, and co-workers with the goal of advancing the availability of medical products for over 40 years. As founder of QST, the predecessor name of Abond CRO Inc., he spearheaded the approval of over 90 regulatory submissions participating in strategic FDA / sponsor meetings, performing statistical analyses as well as directing the company’s work efforts. He has served as CEO and is now the Chief Scientific Officer and a member of the Board of Directors.
Phil Doren, PhDDirector
Dr. Phil Doren is responsible for expanding the company’s service offerings, corporate leadership, risk mitigation, cultivating strategic business opportunities, fostering our well-renowned industry reputation and developing leaders within the organization. Phil has over 25 years of experience in developing and managing partnerships in the CRO industry. He is a decisive leader who has been successful in improving product development programs through high quality data collections completed in reduced time frames.
Veronica Powell, MS, MASDirector
As Abond’s Chief Operating Officer, Veronica is passionate for delivering innovative and client-centric solutions to clinical trial operations. Veronica has an established track record as an effective leader in the industry and within her role at Abond where she ensures the delivery of solutions which are on-time, on-budget and with high quality.
Jason Proos, MSDirector
Jason Proos joined QST (now Abond) in 1999. Jason is responsible for planning, designing, purchasing, installing, monitoring, operating, and maintaining Abond’s IT infrastructure. Jason earned his Masters of Science in Statistics from Western Michigan University.
Susan Walker, MD, FAADDirector
Dr. Walker is an independent consultant and the immediate past director of the Division of Dermatology and Dental Products (DDDP) at the US Food and Drug Administration (FDA). She led this division with responsibilities for review and approval of regulatory applications, including New Drug Applications, Biologics Licensing Applications, Investigational New Drug Applications, labeling supplements, Pediatric Study Plans, Risk Evaluation and Mitigation Strategies, and other submissions. During her tenure as Division Director she led the regulatory approval of dermatology products in the transition from a primarily topical focus to the current broader focus; the introduction of systemic biologic agents.

Dr. Walker currently provides independent consulting services as Susan J. Walker Consulting, LLC., that cover product development and regulatory advice to US and international clients in the pharmaceutical and device industry.

Join Our Team

See Openings